Scholarly article on 3',18'-didehydro-β,ε-caroten-3-ol 33601-07-9 from Journal of the American Chemical Society p. 1951,1952

DOI: 10.1021/ja01250a040

Source and publish data:

Journal of the American Chemical Society p. 1951,1952 (1943)

Update date:2022-08-05

Topics:

Authors:

Zechmeister

Sease Sease

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1021/ja01250a040

Full text of DOI:10.1021/ja01250a040

Products guided by the article

Product name:3',18'-didehydro-β,ε-caroten-3-ol

Cas No:33601-07-9

R&D Labs maybe for 33601-07-9

Nanjing Duly Biotech Co., Ltd

website:http://www.dulynet.com/

Contact:025-84699383 -8003

Address:Room 503, Building 2, Chuangxinhui, No. 61 Wenjing Road, High-tech Development Zone, Pukou District, Nanjing City, Jiangsu Province Nanjing, Jiangsu
ZHEJIANG NHU COMPANY LTD.

Contact:86-575-86132822，86-575-86085355

Address:No.418 Dadao West Road,Qixing Street,Xinchang, Zhejiang Province, China.
Phantom-pharma

Contact:

Address:
Wuhan Better Organic Technology Inc.

Contact:13307163183

Address:Wuhan Economic&Technology Development Zone, Hubei
Changzhou Screw International Trading Co., Ltd.

Contact:13906149256,18001495888

Address:Jiangsu，Jintanqu

Relevant to this article

Doi:10.1021/ja00745a053
(1971)
The synthesis of β-peptides containing guanidino groups

Doi:10.1016/S0960-894X(01)00027-0
(2001)
New silylated iminophosphorano(amino)phosphines Me₃SiN=PPh₂N(r)PPh₂ (R = Et, ⁿPr, ⁿBu). Crystal and molecular structure of trimethylsilyliminophosphorano(propylamino)-diphenylphosphine Me₃SiN=PPh₂N(ⁿPr)PPh₂. Further oxidative derivatization with S, Se, and azides

Doi:10.1021/ic000878r
(2001)
Synthesis of 1,1′-methylenedi[(1R,1′R,3R,3′R,5R,5′R)-8-oxabicyc lo[3.2.1]oct-6-en-3-ol] and derivatives: Precursors of long-chain polyketides

Doi:10.1016/S0957-4166(00)00475-4
(2000)
Gold(I)-Catalyzed Glycosylation with Glycosyl Ynenoates as Donors

Doi:10.1021/acs.orglett.9b03851
(2019)
Regiodivergent Rhodium(I)-Catalyzed Azide-Alkyne Cycloaddition (RhAAC) to Access Either Fully Substituted Sulfonyl-1,2,3-triazoles under Mild Conditions

Doi:10.1021/acs.orglett.8b02794
(2018)

Article Doi

DOI: 10.1021/ja01250a040